Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer. - Bixel, K.; Vetter, M.; Davidson, B.; Berchuck, A.; Cohn, D.; Copeland, L.; Fowler, J.M.; Havrilesky, L.; Lee, P.S.; O'Malley, D.M.; Salani, R.; Valea, F.; et al. (Gynecologic Oncology, 2020)